Molecular and serological diagnosis of toxoplasmosis: a systematic review and meta-analysis.
Journal
Revista do Instituto de Medicina Tropical de Sao Paulo
ISSN: 1678-9946
Titre abrégé: Rev Inst Med Trop Sao Paulo
Pays: Brazil
ID NLM: 7507484
Informations de publication
Date de publication:
2023
2023
Historique:
received:
01
09
2022
accepted:
06
01
2023
entrez:
15
3
2023
pubmed:
16
3
2023
medline:
21
3
2023
Statut:
epublish
Résumé
Toxoplasmosis is an infection of vast worldwide distribution whose etiologic agent is Toxoplasma gondii. This disease can cause problems ranging from mild symptoms to serious conditions, such as encephalitis, miscarriage and blindness. Therefore, it is of utmost importance to perform a diagnosis with reproducible techniques in order to obtain a good prognosis. The aim of this review was to analyze the efficiency of toxoplasmosis diagnostic techniques based on sensitivity and specificity results. Five research platforms in English language were used (Eric, Elsevier, Google Scholar, PubMed and SciELO), which contained data on the diagnosis of toxoplasmosis. The search and selection were performed for studies published prior to June 2021. The search resulted in the inclusion of 13 articles published from 2005 to 2020. The data revealed the use of different samples in the standardization of techniques such as serum, total blood, colostrum and amniotic fluid. The flow cytometry, lateral flow immunoassay and qPCR techniques showed 100% sensitivity, whereas the ELISA, western blotting, qPCR and RE-LAMP techniques achieved 100% specificity. Significantly, the qPCR and LAMP techniques were more accurate when the likelihood ratio was assessed. The meta-analysis identified that ISAGA and western blotting have low sensitivity values and LIASON, ELFA and ELISA, using a silica bioconjugate, also have low specificity values. It was noted that a wide range of methods have high values of sensitivity and specificity. Therefore, the choice of the method will be based on the conditions and its financial viability.
Identifiants
pubmed: 36921207
pii: S0036-46652023000100400
doi: 10.1590/S1678-9946202365019
pmc: PMC10013468
pii:
doi:
Substances chimiques
Antibodies, Protozoan
0
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e19Références
Arq Bras Oftalmol. 2015 Nov-Dec;78(6):356-8
pubmed: 26677037
Braz J Infect Dis. 2012 Nov-Dec;16(6):574-6
pubmed: 23141993
J Pediatr (Rio J). 2016 Nov - Dec;92(6):616-623
pubmed: 27504975
Biotechniques. 2022 Jun;73(1):58-69
pubmed: 35775367
Parasite. 2017;24:41
pubmed: 29119944
Curr Protoc Immunol. 2018 Feb 21;120:5.1.1-5.1.11
pubmed: 29512141
Arch Microbiol. 2020 Sep;202(7):1881-1888
pubmed: 32448961
Exp Parasitol. 2019 Sep;204:107722
pubmed: 31279928
BMC Infect Dis. 2015 Nov 14;15:519
pubmed: 26573138
Clin Vaccine Immunol. 2015 Apr;22(4):456-8
pubmed: 25673306
Medicine (Baltimore). 2016 Mar;95(9):e2979
pubmed: 26945416
PLoS One. 2014 Mar 24;9(3):e90203
pubmed: 24662942
Nucleic Acids Res. 2000 Jun 15;28(12):E63
pubmed: 10871386
Parasite. 2015;22:22
pubmed: 26187780
J Immunol Methods. 2017 Dec;451:61-70
pubmed: 28882612
Food Res Int. 2019 Nov;125:108636
pubmed: 31554047
Acta Trop. 2018 Jan;177:19-24
pubmed: 28964770
Br J Ophthalmol. 2019 Jul;103(7):1008-1012
pubmed: 31088793
Vet Parasitol. 2017 Aug 30;243:199-203
pubmed: 28807294
Exp Parasitol. 2020 Feb 29;211:107869
pubmed: 32119931
BMC Infect Dis. 2020 Sep 22;20(1):694
pubmed: 32962648
Mol Cell Probes. 2015 Apr;29(2):81-5
pubmed: 25681753
Epidemiol Mikrobiol Imunol. 2015 Jun;64(2):59-65
pubmed: 26099608
J Clin Microbiol. 2005 Apr;43(4):1570-4
pubmed: 15814967
Diagn Microbiol Infect Dis. 2015 May;82(1):34-9
pubmed: 25702523
Trends Parasitol. 2016 Jun;32(6):492-506
pubmed: 27167666
J Immunol Methods. 2012 Apr 30;378(1-2):33-43
pubmed: 22343187